What is the price-to-earnings ratio of OPKO Health?
The price-earnings ratio of OPKO Health is currently -5.56.
OPKO Health P/E 2025
OPKO Health P/E
-5.56
Ticker
OPK
ISIN
US68375N1037
WKN
A0MUUJ
As of Jan 13, 2025, OPKO Health's P/E ratio was -5.56, a -33.97% change from the -8.42 P/E ratio recorded in the previous year.
The OPKO Health P/E history
OPKO Health Aktienanalyse
What does OPKO Health do?
OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering OPKO Health's P/E Ratio
The Price to Earnings (P/E) Ratio of OPKO Health is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing OPKO Health's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of OPKO Health is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in OPKO Health’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about OPKO Health stock
How has the price-earnings ratio of OPKO Health changed compared to last year?
The price-to-earnings ratio of OPKO Health has increased by -33.97% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of OPKO Health high compared to other companies?
Yes, the price-to-earnings ratio of OPKO Health is high compared to other companies.
How does an increase in the price-earnings ratio of OPKO Health affect the company?
An increase in the price-earnings ratio of OPKO Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of OPKO Health affect the company?
A decrease in the price-earnings ratio of OPKO Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of OPKO Health?
Some factors that influence the price-earnings ratio of OPKO Health are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does OPKO Health pay?
Over the past 12 months, OPKO Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OPKO Health is expected to pay a dividend of 0 USD.
What is the dividend yield of OPKO Health?
The current dividend yield of OPKO Health is .
When does OPKO Health pay dividends?
OPKO Health pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OPKO Health?
OPKO Health paid dividends every year for the past 0 years.
What is the dividend of OPKO Health?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OPKO Health located?
OPKO Health is assigned to the 'Health' sector.
Wann musste ich die Aktien von OPKO Health kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OPKO Health from 1/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2025.
When did OPKO Health pay the last dividend?
The last dividend was paid out on 1/13/2025.
What was the dividend of OPKO Health in the year 2024?
In the year 2024, OPKO Health distributed 0 USD as dividends.
In which currency does OPKO Health pay out the dividend?
The dividends of OPKO Health are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The OPKO Health stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von OPKO Health
Our stock analysis for OPKO Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OPKO Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
